MICT, Inc. (NASDAQ:MICT) (“MICT”) announced today the results of the proxy vote associated with the Company’s Annual Shareholders’ Meeting. The shareholders approved all five of the resolutions presented in the Definitive Proxy Statement, as sent to the Company’s shareholders on December 8, 2022, including the election of the Board of Directors and approval of the executive officers’ compensation plan; the appointment of Deloitte as independent auditor for the year ended December 31, 2022; an amendment to the Company’s Certificate of Incorporation and an amendment to its Equity Incentive Plan.
Oncocyte Begins Manufacturing Transplant Blood Test
Over 1 million annual testing opportunities in US
Q4 targeted for early access launch
IRVINE, Calif., June 27, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics
